![Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b141e8c36fd0ceaec628488a500cd5aad3141e4d/4-Table1-1.png)
Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar
![Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - Journal of Stroke and Cerebrovascular Diseases Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - Journal of Stroke and Cerebrovascular Diseases](https://www.strokejournal.org/cms/asset/d34f16a5-a98d-4834-afd8-0fe7483b7ef0/gr1.jpg)
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - Journal of Stroke and Cerebrovascular Diseases
![Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study | Scientific Reports Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-018-21884-y/MediaObjects/41598_2018_21884_Fig1_HTML.jpg)
Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study | Scientific Reports
![Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants - ScienceDirect Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720361052-fx1.jpg)
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants - ScienceDirect
![The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? - American College of Cardiology The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? - American College of Cardiology](https://www.acc.org/-/media/Non-Clinical/Migration-Content/Hot-Topics/Anticoagulation-Management/The-New-Oral-Anticoagulants-in-Atrial-Fibrillation-Once-or-Twice-Daily/AM_HotTopic_Dec13_Table1.gif?la=en&hash=CDD5776702B830B601B0A7851CB554A1B900CBA6)
The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? - American College of Cardiology
![Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109718349982-fx1.jpg)
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect
![Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Semantic Scholar Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9157d42f3c05295de4cc1cf1fa45be4bda52f85b/2-Figure1-1.png)
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Semantic Scholar
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS | PLOS ONE
![Remedial dosing recommendation for delayed or missed rivaroxaban doses for patients with non-valvular atrial fibrillation based on Monte Carlo simulation | medRxiv Remedial dosing recommendation for delayed or missed rivaroxaban doses for patients with non-valvular atrial fibrillation based on Monte Carlo simulation | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2020/08/14/2020.08.10.20170795/F2.large.jpg)
Remedial dosing recommendation for delayed or missed rivaroxaban doses for patients with non-valvular atrial fibrillation based on Monte Carlo simulation | medRxiv
![Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Stroke Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Stroke](https://www.ahajournals.org/cms/asset/59444155-3a95-4d91-bbd5-32c425bec925/1140fig01.gif)
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Stroke
![Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review | Article Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review | Article](https://assets.cureus.com/uploads/figure/file/353942/lightbox_8d54b280b1c311eca14305bd0e694476-Figure-5.png)
Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review | Article
![What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg? - Sung Soo Kim, Ki Hong Lee, Nam Sik Yoon, Hyung Wook Park, Jeong Gwan Cho, What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg? - Sung Soo Kim, Ki Hong Lee, Nam Sik Yoon, Hyung Wook Park, Jeong Gwan Cho,](https://journals.sagepub.com/cms/10.1177/10760296211061148/asset/images/large/10.1177_10760296211061148-fig1.jpeg)